Tudor Investment Corp
ALXN

Tudor Investment Corp’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-907,855
Closed -$167M 2192
2021
Q2
$167M Buy
907,855
+380,114
+72% +$69.8M 3.15% 1
2021
Q1
$80.7M Buy
527,741
+194,364
+58% +$29.7M 1.62% 3
2020
Q4
$52.1M Buy
333,377
+261,377
+363% +$40.8M 1.47% 9
2020
Q3
$8.24M Buy
72,000
+52,405
+267% +$6M 0.36% 34
2020
Q2
$2.2M Sell
19,595
-4,502
-19% -$505K 0.11% 217
2020
Q1
$2.16M Sell
24,097
-42,873
-64% -$3.85M 0.19% 83
2019
Q4
$7.24M Sell
66,970
-22,101
-25% -$2.39M 0.32% 48
2019
Q3
$8.72M Buy
89,071
+27,817
+45% +$2.72M 0.3% 47
2019
Q2
$8.02M Buy
61,254
+43,599
+247% +$5.71M 0.23% 37
2019
Q1
$2.39M Sell
17,655
-15,937
-47% -$2.15M 0.1% 223
2018
Q4
$3.27M Buy
33,592
+26,725
+389% +$2.6M 0.06% 93
2018
Q3
$955K Sell
6,867
-30,876
-82% -$4.29M 0.02% 472
2018
Q2
$4.69M Buy
37,743
+17,541
+87% +$2.18M 0.16% 81
2018
Q1
$2.25M Buy
20,202
+17,938
+792% +$2M 0.07% 128
2017
Q4
$271K Sell
2,264
-11,161
-83% -$1.34M 0.01% 851
2017
Q3
$1.88M Buy
13,425
+6,218
+86% +$872K 0.05% 216
2017
Q2
$877K Buy
7,207
+170
+2% +$20.7K 0.03% 374
2017
Q1
$853K Buy
7,037
+5,337
+314% +$647K 0.03% 447
2016
Q4
$208K Sell
1,700
-151,811
-99% -$18.6M 0.01% 1190
2016
Q3
$18.8M Buy
153,511
+140,182
+1,052% +$17.2M 0.44% 36
2016
Q2
$1.56M Buy
+13,329
New +$1.56M 0.03% 225
2015
Q3
Sell
-1,501
Closed -$271K 1741
2015
Q2
$271K Sell
1,501
-1,730
-54% -$312K 0.01% 1126
2015
Q1
$560K Buy
3,231
+1,744
+117% +$302K 0.02% 662
2014
Q4
$275K Sell
1,487
-1,633
-52% -$302K 0.01% 1075
2014
Q3
$517K Buy
3,120
+1,794
+135% +$297K 0.02% 638
2014
Q2
$207K Sell
1,326
-4,399
-77% -$687K 0.01% 1017
2014
Q1
$871K Buy
+5,725
New +$871K 0.04% 235
2013
Q3
Sell
-3,800
Closed -$351K 987
2013
Q2
$351K Buy
+3,800
New +$351K 0.03% 475